Dr Moro continues to come thru with each of his novel ideas on how to capitalize on Recaf. However, if they ever want the share price to reflect the true value of the company, there has to be some real change in strategy as far as releasing future news. I can't for the life of me understand why there aren't a significant number of presentations that can demonstrate the potential at any or all of the medical, oncology, or pharmaceutical conventions. It is definitely time to stop being timid and quit wasting shareholder money on small-time daytrading newsletters that send out press releases only read by a handful of pennystock manipulators. It really is condescending. In my opinion, Biocurex has paid its dues and is deserving of a worldwide reputation as an up-in-comer and a company not only to associate with, but to watch out for. I have a feeling that Dr Moro is brilliant, but from all the skeletons dug up by Goldseeker I have come to the conclusion that his "board of directors" are way out of their league. Their previous endeavors never involved a company with such explosive potential that either : 1)They are poor salesmen 2)They are inexperienced with negotiations 3)They only can come up with a marketing strategy fit for a penny stock.
All of the press releases should be big news not only for investors, but for the entire world, and when you pay someone to print this for you it is taken as an advertisement and always leaves a bit of suspicion. They should have at least been on the local news in Canada. They could present at any number of universities, hospitals, or diagnostic conferences. They should be making the public at large known of what they have discovered and laid claim to.
AI
